Journal Specialty Index
Cardiology
Topic | Issue |
Statin Alternatives in the Primary Prevention of Cardiovascular Disease | MAY 2024 • VOL. 16 • NO. 5 |
Resistant Hypertension | MAY 2024 • VOL. 16 • NO. 5 |
Overview of Endovascular Treatment for Deep Vein Thrombosis Associated With May–Thurner Syndrome | MAY 2024 • VOL. 16 • NO. 5 |
Cardiovascular Effects of Glucocorticoids for Rheumatoid Arthritis: Friend or Foe? | AUGUST 2023 ‧ VOL. 15 ‧ NO. 6 |
Cardiometabolic Risks of the Sugar Substitute Erythritol | JULY 2023 ‧ VOL. 15 ‧ NO. 5 |
SGLT2 Inhibitors: Latest Update | JULY 2023 ‧ VOL. 15 ‧ NO. 5 |
Beyond Conventional Indications of ECMO | APRIL 2023 ‧ VOL. 15 ‧ NO. 2 |
The Expanding Pharmacological Armamentarium Against Heart Failure: Is There a Limit? | APRIL 2023 ‧ VOL. 15 ‧ NO. 2 |
An Update on Medical Treatment for Heart Failure With Reduced Ejection Fraction | APRIL 2023 ‧ VOL. 15 ‧ NO. 2 |
Diabetes and Cardiology - A Concise and Comprehensive 2022 Update for Frontline Family Doctors | JULY 2022 ‧ VOL. 14 ‧ NO. 6 |
Update on Glucagon-like Peptide 1 Receptor Agonists | JULY 2022 ‧ VOL. 14 ‧ NO. 6 |
Practical Guidance From EAS for Combination Lipid-Modifying Therapy in High-and Very-High-Risk Patients | MAY 2022 ‧ VOL. 14 ‧ NO. 4 |
To Harden Your Heart Makes You Feel Bad | MAY 2022 ‧ VOL. 14 ‧ NO. 4 |
Advances in LDL-C Management: What's Next? | MAY 2022 ‧ VOL. 14 ‧ NO. 4 |
Order Versus Chaos in the Elderly | FEBRUARY 2021 ‧ VOL. 13 ‧ NO. 2 |
Current Guidance on Management of Hypertension and the Hong Kong Perspective | FEBRUARY 2021 ‧ VOL. 13 ‧ NO. 2 |
What Is New for Atrial Fibrillation From the 2020 ESC Guidelines? | FEBRUARY 2021 ‧ VOL. 13 ‧ NO. 2 |
Advances in the Treatment of Heart Failure | FEBRUARY 2021 ‧ VOL. 13 ‧ NO. 2 |
Hypertensive Emergencies | FEBRUARY 2021 ‧ VOL. 13 ‧ NO. 2 |
Use of Sodium-Glucose Cotransporter-2 Inhibitors in Heart Failur | APRIL 2020 ‧ VOL. 12 ‧ NO. 4 |
The Management of Hyperuricaemia in Chronic Kidney Disease and Cardiovascular Disorders | MARCH 2020 ‧ VOL. 12 ‧ NO. 3 |
Diabetes Breakthrough Treatment for Cardiovascular Diseases and Beyond | FEBRUARY 2020 ‧ VOL. 12 ‧ NO. 2 |
Learnings From a Patient Complaining of Dyspepsia | FEBRUARY 2020 ‧ VOL. 12 ‧ NO. 2 |
Current Status of Transcatheter Aortic Valve Implantation (TAVI) | FEBRUARY 2020 ‧ VOL. 12 ‧ NO. 2 |
Left Atrial Appendage Occlusion for Stroke Prevention: Are We Ready? | FEBRUARY 2020 ‧ VOL. 12 ‧ NO. 2 |
Resistant Hypertension | FEBRUARY 2020 ‧ VOL. 12 ‧ NO. 2 |
Cardiology, COVID-19 and Beyond | FEBRUARY 2020 ‧ VOL. 12 ‧ NO. 2 |
Cardio-oncology - Where Breast Cancer and Cardiovascular Disease Intersect | JULY 2019 ‧ VOL. 11 ‧ NO. 5 |
Update on Idiopathic Pulmonary Fibrosis | MAY 2019 ‧ VOL. 11 ‧ NO. 4 |
Sudden Cardiac Death in Athletes and Screening for Prevention | APRIL 2019 ‧ VOL. 11 ‧ NO. 3 |
Food Supplements and Cholesterol/Cardiovascular Health | NOVEMBER 2018 ‧ VOL. 10 ‧ NO. 7 |
Atherosclerotic Cardiovascular Disease Events: From Stenosis to Vulnerable Plaque and Vulnerable Patient | NOVEMBER 2018 ‧ VOL. 10 ‧ NO. 7 |
Reducing LDL Cholesterol to Prevent Atherosclerotic Cardiovascular Disease | AUGUST 2018 ‧ VOL. 10 ‧ NO. 5 |
Coronary Artery Disease Screening in Patients with Type 2 Diabetes | APRIL 2018 ‧ VOL. 10 ‧ NO. 3 |
Latest Insights on the Treatment of Dyslipidemia | NOVEMBER 2017 ‧ VOL. 9 ‧ NO. 7 |
Update in Chronic Heart Failure Treatment | NOVEMBER 2016 ‧ VOL. 8 ‧ NO. 7 |
Gastrointestinal Bleeding in Patients Treated with Novel Oral Anticoagulants: Risk and Prevention | SEPTEMBER 2016 ‧ VOL. 8 ‧ NO. 6 |
The Important Role of Diet in the Management of Hypercholesterolemia and Prevention of Coronary Heart Disease | JULY 2016 ‧ VOL. 8 ‧ NO. 5 |
New Expert Opinion on the Role of Vasodilating Beta-blockers in Hypertension Management | JANUARY 2016 ‧ VOL. 8 ‧ NO. 1 |
Antibiotic Prophylaxis to Prevent Infective Endocarditis | NOVEMBER 2015 ‧ VOL. 7 ‧ NO. 6 |
Role of Probucol in the Current Treatment of Atherosclerosis and Vascular Disease | NOVEMBER 2015 ‧ VOL. 7 ‧ NO. 6 |
Probucol: Reappraisal of an Old Drug for Atherosclerosis | MAY 2015 ‧ VOL. 7 ‧ NO. 3 |
Latest Update on Hypertension Guidelines: Combination Therapy and More | NOVEMBER 2014 ‧ VOL. 6 ‧ NO. 6 |
An Update on Transcatheter Aortic Valve Implantation | SEPTEMBER 2014 ‧ VOL. 6 ‧ NO. 5 |
An Update in the Management of Atrial Fibrillation | JULY 2014 ‧ VOL. 6 ‧ NO. 4 |
Update on the Use of Angiotensin Receptor Blockers in Hypertension: A Focus on Azilsartan Medoxomil | JUNE 2014 ‧ VOL. 6 ‧ NO. 3 |
Updates on Management of Coronary Artery Disease | DECEMBER 2013 ‧ VOL. 5 ‧ NO. 7 |
Blood Pressure Variability: Is It Important and How Can We Assess It? | DECEMBER 2013 ‧ VOL. 5 ‧ NO. 7 |
Cardiovascular Risk Factors, Morbidity and Mortality in Psoriasis | NOVEMBER 2013 ‧ VOL. 5 ‧ NO. 6 |
Heart Rate Reduction as a Goal in the Management of Cardiovascular Risk | MARCH 2013 ‧ VOL. 5 ‧ NO. 2 |
Advances in the Management of Coronary Artery Disease | DECEMBER 2012 ‧ VOL. 4 ‧ No. 7 |
Contemporary Guidelines on Cardiovascular Disease Prevention and Updated Recommendations on the Use of Antithrombotics | SEPTEMBER 2012 ‧ VOL. 4 ‧ NO. 5 |
Primary Prevention of Sudden Cardiac Death | MAY 2012 ‧ VOL. 4 ‧ NO. 3 |
Hypertension and Atrial Fibrillation | MAY 2012 ‧ VOL. 4 ‧ NO. 3 |
The Role of Combination Therapy in the Management of Hypertension | MAY 2012 ‧ VOL. 4 ‧ NO. 3 |
Cardiovascular Risk in Patients With Psoriatic Arthritis | JANUARY 2012 ‧ VOL. 4 ‧ NO. 1 |
Management of Adverse Gastrointestinal Events in Patients on Antiplatelet Therapy, Part II: Gastrointestinal Bleeding Induced by Clopidogrel or Dual Antiplatelet Therapy | JANUARY 2012 ‧ VOL. 4 ‧ NO. 1 |
Managing Atrial Fibrillation to Reduce Mortality and Morbidity | DECEMBER 2011 ‧ VOL. 3 ‧ NO. 7 |
Niacin for the Treatment of Dyslipidaemia and Atherosclerosis | JULY 2011 ‧ VOL. 3 ‧ NO. 4 |
Management of Adverse Gastrointestinal Events in Patients on Antiplatelet Therapy, Part I: Gastrointestinal Bleeding Induced by Low-dose Aspirin | MARCH 2011 ‧ VOL. 3 ‧ NO. 2 |
Percutaneous Coronary Intervention for Patients With Acute Myocardial Infarction | MARCH 2011 ‧ VOL. 3 ‧ NO. 2 |
Treatment of Left Main Disease in 2011 | JANUARY 2011 ‧ VOL. 3 ‧ NO. 1 |
Angiotensin Receptor Blockers - Across the Cardiovascular Continuum | DECEMBER 2010 ‧ VOL. 2 ‧ NO. 8 |
Case Study: A 75-year-old Gentleman With Recurrent Palpitation | SEPTEMBER 2010 ‧ VOL. 2 ‧ NO. 6 |
Sleep Apnoea and Arrthymias | MARCH 2010 ‧ VOL. 2 ‧ NO. 2 |
Coronary Artery Disease: Pills, Stents or Surgeon's Knife? | DECEMBER 2009 ‧ VOL. 1 ‧ NO. 6 |
The Post-cardiac Arrest Syndrome | JULY 2009 ‧ VOL. 1 ‧ NO. 3 |
Update on Management of Heart Failure | JANUARY 2009 ‧ VOL. 1 ‧ NO. 1 |
Approaches to Carotid Stenosis | JANUARY 2009 ‧ VOL. 1 ‧ NO. 1 |
Utilizing Cardiac CT for the Detection of Coronary Artery Disease | JANUARY 2009 ‧ VOL. 1 ‧ NO. 1 |
Heart Disease Does not Equate Coronary Artery Disease | JANUARY 2009 ‧ VOL. 1 ‧ NO. 1 |